InvestorsHub Logo
Followers 0
Posts 1856
Boards Moderated 0
Alias Born 03/13/2015

Re: MI Dendream post# 428424

Tuesday, 12/21/2021 10:29:40 AM

Tuesday, December 21, 2021 10:29:40 AM

Post# of 702500
MI,

How many patients are available to treat in the specials program? And how much does treatment cost per-patient? If you could provide some numbers and added color to the situation (ramifications of the MHRA approval) would be greatly appreciated.

Also, I am assuming this will lead to revenue before the drug is officially approved? I know in other Countrys, Australia for instance, patients can stay on a Open Label Extension (OLE) but the Company absorbs the cost of the drug. Anavex Life Sciences ($AVXL) has been doing this with the Alzheimer's, Parkinson's and Rett trial in Australia and Spain. This "specials" program in the UK is different?

-Fireman
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News